Article Versions Notes

Kim MY, Lee H, Ji SY, Kim SY, Hwangbo H, Park S-H, Kim G-Y, Park C, Leem S-H, Hong SH, et al. Induction of Apoptosis by Isoalantolactone in Human Hepatocellular Carcinoma Hep3B Cells through Activation of the ROS-Dependent JNK Signaling Pathway. Pharmaceutics. 2021; 13(10):1627. https://doi.org/10.3390/pharmaceutics13101627

Kim, Min Yeong, Hyesook Lee, Seon Yeong Ji, So Young Kim, Hyun Hwangbo, Shin-Hyung Park, Gi-Young Kim, Cheol Park, Sun-Hee Leem, Su Hyun Hong, and et al. 2021. "Induction of Apoptosis by Isoalantolactone in Human Hepatocellular Carcinoma Hep3B Cells through Activation of the ROS-Dependent JNK Signaling Pathway" Pharmaceutics 13, no. 10: 1627. https://doi.org/10.3390/pharmaceutics13101627

Kim, M. Y., Lee, H., Ji, S. Y., Kim, S. Y., Hwangbo, H., Park, S.-H., Kim, G.-Y., Park, C., Leem, S.-H., Hong, S. H., & Choi, Y. H. (2021). Induction of Apoptosis by Isoalantolactone in Human Hepatocellular Carcinoma Hep3B Cells through Activation of the ROS-Dependent JNK Signaling Pathway. Pharmaceutics, 13(10), 1627. https://doi.org/10.3390/pharmaceutics13101627